Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

43.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

2.0K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
2.0K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

1.2K
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
1.2K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58
Hepatitis01:25

Hepatitis

86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

1.5K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell analysis of HIV expression and integration sites reveals robust viral expression across diverse chromatin environments.

Microbiology spectrum·2026
Same author

A screen of chromatin-targeting compounds identifies TAF1 as a novel regulator of HIV latency.

mBio·2026
Same author

MVA.HIVconsvX vaccination-evoked T cell expansion inversely associates with age in people with HIV-1 on antiretroviral therapy.

The Journal of clinical investigation·2026
Same author

The ENL-USP7 Complex Regulates HIV Latency Through BRD4 Stabilization.

bioRxiv : the preprint server for biology·2026
Same author

Histone decrotonylation plays a distinct role in HIV latency.

Science advances·2026
Same author

Single cell multiomic analysis of the impact of Delta-9-tetrahydrocannabinol on HIV infected CD4 T cells.

Journal of cannabis research·2026
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

Related Experiment Video

Updated: May 2, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.2K

How Might We Cure HIV?

David M Margolis1

  • 1Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA, dmargo@med.unc.edu.

Current Infectious Disease Reports
|February 25, 2014
PubMed
Summary
This summary is machine-generated.

Antiretroviral therapy (ART) suppresses HIV-1 but does not eliminate it from latent reservoirs. Innovative strategies combining immune augmentation with therapies that induce viral expression are needed to eradicate HIV infection.

More Related Videos

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

10.8K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

20.3K

Related Experiment Videos

Last Updated: May 2, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.2K
Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

10.8K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

20.3K

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Antiretroviral therapy (ART) effectively suppresses HIV-1 replication but fails to eliminate the virus from latent reservoirs.
  • Life-long ART presents a significant burden for individuals with HIV infection globally.
  • Eradicating HIV infection is crucial to obviate the need for continuous medical therapy.

Purpose of the Study:

  • To explore innovative therapeutic strategies for eradicating latent HIV-1 reservoirs.
  • To investigate methods for clearing latently infected cells and achieving a functional cure for HIV.
  • To assess the potential of combining viral induction with immune-based therapies.

Main Methods:

  • Investigating the induction of latent proviral genomes in resting CD4+ T cells using histone deacetylase (HDAC) inhibitors like suberoylanilide hydroxamic acid (SAHA).
  • Evaluating the augmentation of HIV-specific immune responses through ex vivo expansion of cytotoxic T-cell lymphocytes.
  • Assessing cellular vaccinations using dendritic cells to enhance immune clearance of infected cells.

Main Results:

  • Inducing viral expression alone may not be sufficient for complete clearance of latently infected cells.
  • Ex vivo expansion of HIV-specific cytotoxic T-cell lymphocytes has shown potential for augmenting immune responses in vivo.
  • Dendritic cell-based vaccinations have also demonstrated capacity for immune augmentation.

Conclusions:

  • Eradicating HIV infection likely requires multifaceted approaches.
  • Combining strategies that induce viral expression with those that enhance HIV-specific immunity is a promising avenue.
  • Further research into combination therapies is essential for achieving a cure for HIV infection.